Use of octreotide as second-line treatment for concurrent chemoradiation induced diarrhea refractory to loperamide.

Topkan, ESelek, U2024-08-042024-08-0420040732-183Xhttps://hdl.handle.net/11616/10469340th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Use of octreotide as second-line treatment for concurrent chemoradiation induced diarrhea refractory to loperamide.Conference Object2214295S295SWOS:000223512401168Q1